330350.KS · 위더스제약
South Korea · RS rating 41 · As of 2026-10-14
| Price | 6,760.00 KRW |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 11 / 61 / 60 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 21 / 36 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -50.5% |
| Sales growth Q/Q | +3.0% |
| Distance from 52-week high | +43.4% |
| Market cap (USD) | $69.2M |